Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models.
暂无分享,去创建一个
M. Daly | B. Rosner | J. Seddon | Robyn C Reynolds | Yi Yu
[1] Aaron Y. Lee,et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) , 2010, Proceedings of the National Academy of Sciences.
[2] B. Rosner,et al. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. , 2006, Archives of ophthalmology.
[3] E. Souied,et al. [Epidemiology of age related macular degeneration]. , 2009, Journal Francais d'Ophtalmologie.
[4] B. Rosner,et al. Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration , 2010, Molecular vision.
[5] Ronald Klein,et al. The epidemiology of age-related macular degeneration. , 2004, American journal of ophthalmology.
[6] T. Peto,et al. The symmetry of phenotype between eyes of patients with early and late bilateral age-related macular degeneration (AMD) , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.
[7] L. D. Del Priore,et al. Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. , 1999, Survey of ophthalmology.
[8] M. Daly,et al. Variation near complement factor I is associated with risk of advanced AMD , 2009, European Journal of Human Genetics.
[9] Yun Li,et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.
[10] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[12] Christine A Curcio,et al. The oil spill in ageing Bruch membrane , 2011, British Journal of Ophthalmology.
[13] Johanna M Seddon,et al. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. , 2011, Ophthalmology.
[14] Hein Putter,et al. The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models , 2010, Comput. Methods Programs Biomed..
[15] Margaret A. Pericak-Vance,et al. Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.
[16] D. Weeks,et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. , 2005, American journal of human genetics.
[17] N. Camp,et al. A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration , 2006, Science.
[18] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[19] Aaron Y. Lee,et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration , 2011, Human molecular genetics.
[20] B. Rosner,et al. Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. , 2010, Ophthalmology.
[21] Lars G Fritsche,et al. Evidence of association of APOE with age‐related macular degeneration ‐ a pooled analysis of 15 studies , 2011, Human mutation.
[22] Johanna M Seddon,et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.
[23] Joan W. Miller,et al. Albert & Jakobiec's principles and practice of ophthalmology , 2008 .
[24] Chi Pui Pang,et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. , 2007, Science.
[25] M. Killingsworth,et al. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study , 1999, The British journal of ophthalmology.
[26] I. Deary,et al. Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.
[27] A. Linneberg,et al. Small, hard macular drusen and peripheral drusen: associations with AMD genotypes in the Inter99 Eye Study. , 2010, Investigative ophthalmology & visual science.
[28] H Putter,et al. Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.
[29] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[30] Johanna M Seddon,et al. Evaluation of the clinical age-related maculopathy staging system. , 2006, Ophthalmology.
[31] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[32] Johanna M Seddon,et al. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. , 2009, Investigative ophthalmology & visual science.
[33] Johanna M Seddon,et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration , 2007, Nature Genetics.
[34] S. Fisher,et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .
[35] M. Daly,et al. Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.
[36] B. J. Klevering,et al. Basal laminar drusen caused by compound heterozygous variants in the CFH gene. , 2008, American journal of human genetics.